Page last updated: 2024-09-05

rpr 104632 and tenocyclidine

rpr 104632 has been researched along with tenocyclidine in 1 studies

Compound Research Comparison

Studies
(rpr 104632)
Trials
(rpr 104632)
Recent Studies (post-2010)
(rpr 104632)
Studies
(tenocyclidine)
Trials
(tenocyclidine)
Recent Studies (post-2010) (tenocyclidine)
50026503

Protein Interaction Comparison

ProteinTaxonomyrpr 104632 (IC50)tenocyclidine (IC50)
Lysosomal Pro-X carboxypeptidaseHomo sapiens (human)0.02
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)0.24

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchard, JC; Boireau, A; Bordier, F; Burgevin, MC; Chevet, T; Daniel, M; Doble, A; Durand, G; Jimonet, P; Malgouris, C; Meunier, M; Mignani, S; Miquet, JM; Pény, C1

Other Studies

1 other study(ies) available for rpr 104632 and tenocyclidine

ArticleYear
Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
    European journal of pharmacology, 1996, Apr-11, Volume: 300, Issue:3

    Topics: Aminoquinolines; Animals; Benzothiadiazines; Binding, Competitive; Cerebral Cortex; Cyclic GMP; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Kynurenic Acid; Nerve Degeneration; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1996